Memantine Grindeks (Memantine Hydrochloride)

Memantine works as a non‑competitive antagonist of the NMDA receptor. By blocking excessive calcium influx caused by prolonged glutamate activation, it reduces neuronal excitotoxicity while preserving normal synaptic transmission, which can help stabilize brain function in Alzheimer’s patients.

The specific dose of Memantine Grindeks is determined by the prescribing clinician based on the patient’s condition, renal function, and response to therapy. Physicians typically start with a low dose and titrate upward, but exact regimens should only be provided by a qualified health professional.

Safety data for memantine in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative for Alzheimer’s disease is the acetylcholinesterase inhibitor class (e.g., donepezil). While acetylcholinesterase inhibitors increase cholinergic activity, memantine reduces glutamate‑mediated excitotoxicity. Both classes may be used together for synergistic effects, but they act on different pathways and have distinct side‑effect profiles.

Memantine Grindeks should be stored below 25 °C in its original packaging, protected from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments to maintain its stability.

The medication is supplied as an oral tablet and should be taken with water. It is usually administered once daily, but the exact schedule is set by the prescriber. Tablets should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse reactions include seizures, severe allergic responses such as anaphylaxis, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience any signs of these reactions, such as uncontrolled shaking, rash, swelling, or difficulty breathing.

Memantine is contraindicated in patients with known hypersensitivity to memantine or any of its excipients. Caution is also advised for individuals with severe renal impairment, uncontrolled hypertension, or those taking other NMDA antagonists, as these conditions may increase the risk of adverse effects.